<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04172727</url>
  </required_header>
  <id_info>
    <org_study_id>AUTF ANESTHESIAOBSTETRIC</org_study_id>
    <nct_id>NCT04172727</nct_id>
  </id_info>
  <brief_title>Subarachnoid Block With Ultrasound-Guided Transversalis Fascia Plane Block for Cesarean Section</brief_title>
  <official_title>Subarachnoid Block With Ultrasound-Guided Transversalis Fascia Plane Block for Cesarean Sections: A Randomized Placebo-Controlled Double-Blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ataturk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ataturk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative pain management is critical for the fulfillment of the maternal duties. The
      transversalis fascia plane (TFP) block provides adequate postoperative analgesia in the T12
      and L1 dermatomes. The aim of this study was to investigate the effect of the TFP block on
      postoperative opioid consumption and pain scores in patients undergoing cesarean section (CS)
      under spinal anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">June 1, 2019</completion_date>
  <primary_completion_date type="Actual">May 1, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>opioid consumption</measure>
    <time_frame>Postoperative first 24hour</time_frame>
    <description>morphine consumption first 24hour</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain scores</measure>
    <time_frame>postoperative 0-24 hours</time_frame>
    <description>Visual Analogue Scale (0-10)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Caesarean Section</condition>
  <condition>Pain, Acute</condition>
  <arm_group>
    <arm_group_label>ultrasound guided transversalis fascia plane block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 mL of 0.25% bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ultrasound guided sham block</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>20 mL of saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Hcl 0.25% Inj</intervention_name>
    <description>ultrasound-guided bilateral TFP block with 20 mL of 0.25% bupivacaine</description>
    <arm_group_label>ultrasound guided transversalis fascia plane block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline 0.9%</intervention_name>
    <description>ultrasound-guided bilateral TFP block with 20 mL of saline 0.9%</description>
    <arm_group_label>ultrasound guided sham block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged between 18 and 45

          -  American Society of Anesthesiologists (ASA) physical score I or II

        Exclusion Criteria:

          -  Patients who received general anesthesia

          -  hypersensitivity to the agents to be used

          -  body mass index (BMI) greater than 35 kg/m2

          -  coagulopathy

          -  local infections

          -  opioid addiction

          -  pregnancy-related hypertension or diabetes mellitus
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women aged between 18 and 45 with American Society of Anesthesiologists (ASA) physical score I or II undergoing elective CS</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ali Ahıskalıoğlu</name>
      <address>
        <city>Erzurum</city>
        <zip>25100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Serifsoy TE, Tulgar S, Selvi O, Senturk O, Ilter E, Peker BH, Ozer Z. Evaluation of ultrasound-guided transversalis fascia plane block for postoperative analgesia in cesarean section: A prospective, randomized, controlled clinical trial. J Clin Anesth. 2020 Feb;59:56-60. doi: 10.1016/j.jclinane.2019.06.025. Epub 2019 Jun 27.</citation>
    <PMID>31255890</PMID>
  </reference>
  <reference>
    <citation>Hebbard PD. Transversalis fascia plane block, a novel ultrasound-guided abdominal wall nerve block. Can J Anaesth. 2009 Aug;56(8):618-20. doi: 10.1007/s12630-009-9110-1. Epub 2009 Jun 4.</citation>
    <PMID>19495909</PMID>
  </reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 20, 2019</study_first_submitted>
  <study_first_submitted_qc>November 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2019</study_first_posted>
  <last_update_submitted>November 20, 2019</last_update_submitted>
  <last_update_submitted_qc>November 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ataturk University</investigator_affiliation>
    <investigator_full_name>Ali Ahiskalioglu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

